XML 28 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 102,891 $ 63,547
Investments in marketable securities 14,857 128,134
Trade receivables, net 260,522 109,964
Inventory 62,605 38,791
Prepaid manufacturing 23,657 17,880
Other prepaids and current assets 11,099 22,918
Total current assets 475,631 381,234
Property and equipment, net 5,119 8,754
Inventory, non-current 67,495 76,260
Intangible assets, net 71,673 5,931
Other assets, non-current 9,686 8,668
Total assets 629,604 480,847
Current liabilities:    
Accounts payable 35,219 11,526
Accrued rebates, fees and reserves 169,645 54,461
Accrued compensation 21,521 22,610
Accrued and other current liabilities 105,386 50,097
Total current liabilities 331,771 138,694
Term loans 246,481 245,483
Convertible notes 226,888 225,575
Lease liabilities, non-current 5,328 5,046
Other liabilities, non-current 12,561 3,467
Total liabilities 823,029 618,265
Commitments and contingencies (Note 9)
Stockholders' deficit:    
Common stock ($0.0001 par value; shares authorized: 300,000,000; shares issued and outstanding: 112,215,260 and 78,851,516 at December 31, 2023 and 2022, respectively) 11 8
Additional paid-in capital 1,386,312 1,204,431
Accumulated other comprehensive loss (248) (249)
Accumulated deficit (1,579,500) (1,341,608)
Total stockholders' deficit (193,425) (137,418)
Total liabilities and stockholders' deficit $ 629,604 $ 480,847